Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zi-Shen-Gu-Sui Decoction (ZSGSD) is a traditional Chinese medicinal (TCM) formula clinically applied in the treatment of colorectal cancer (CRC) and for postoperative rehabilitation. Pharmacological and experimental evidence suggests that ZSGSD exerts anti-tumor efficacy by inhibiting the PI3K/AKT/mTOR signaling axis, a pathway frequently dysregulated in various malignancies that promotes cell growth, proliferation, and survival. By modulating this pathway, the decoction suppresses tumor progression and may improve survival outcomes in advanced stages of the disease. As a multi-component herbal preparation, it is typically administered orally as a liquid decoction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zi-Shen-Gu-Sui Decoction.